It has just been announced that our client HIL Applied Medical Ltd. has acquired US-based Nanolabz Inc. en route to developing …
We are very proud of our client, eyeSight Mobile Technologies, for closing a $20,000,000 strategic transaction with Kuang-Chi Science, and …
Katzenell Dimant represents Multiphy Ltd. in an $8.5 million financing round led by strategic partners and VCs. Read the press …
Katzenell Dimant represents Kitov Pharmaceuticals Holdings Ltd. in publishing a prospectus for public issuance of rights to purchase its securities and registration …
Katzenell Dimant represents Agri Invest Ltd. in a transaction for the sale of the control in the company, for the …
Katzenell Dimant represents the shareholders of TradeFX Limited in the sale of a majority of their shares to Playtech plc (LSE:PTEC) for …
Katzenell Dimant represents Kitov Pharmaceuticals Holdings Ltd. (NASDAQ/TASE:KTOV) in several shelf offerings of its securities to the public. Kitov Pharmaceuticals is an …
Katzenell Dimant represents SteadyMed Ltd. in its Nasdaq IPO: on March 25, 2015, the company announced the closing of its …
Katzenell Dimant represents Nextgen Biomed Ltd. (TLV: NXGN) in several shelf offerings of its securities to the public. Nextgen-Biomed is …